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Abstract: Dietary fiber and whole grains contain a unique blend of bioactive components 
including  resistant  starches,  vitamins,  minerals,  phytochemicals  and  antioxidants.  As  a 
result, research regarding their potential health benefits has received considerable attention 
in the last several decades. Epidemiological and clinical studies demonstrate that intake of 
dietary fiber and whole grain is inversely related to obesity, type two diabetes, cancer and 
cardiovascular  disease  (CVD).  Defining  dietary  fiber  is  a  divergent  process  and  is 
dependent  on  both  nutrition  and  analytical  concepts.  The  most  common  and  accepted 
definition is based on nutritional physiology. Generally speaking, dietary fiber is the edible 
parts of plants, or similar carbohydrates, that are resistant to digestion and absorption in the 
small  intestine.  Dietary  fiber  can  be  separated  into  many  different  fractions.  Recent 
research has begun to isolate these components and determine if increasing their levels in a 
diet is beneficial to human health. These fractions include arabinoxylan, inulin, pectin, 
bran, cellulose, β-glucan and resistant starch. The study of these components may give us a 
better  understanding  of  how  and  why  dietary  fiber  may  decrease  the  risk  for  certain 
diseases. The mechanisms behind the reported effects of dietary fiber on metabolic health 
are not well established. It is speculated to be a result of changes in intestinal viscosity, 
nutrient absorption, rate of passage, production of short chain fatty acids and production of 
gut hormones. Given the inconsistencies reported between studies this review will examine 
the most up to date data concerning dietary fiber and its effects on metabolic health.  
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cellulose; β-glucan resistant starch  
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1. Introduction 
Dietary fiber and whole grains contain a unique blend of bioactive components including resistant 
starches, vitamins, minerals, phytochemicals and antioxidants. As a result, research regarding their 
potential  health  benefits  has  received  considerable  attention  in  the  last  several  decades. 
Epidemiological and clinical studies demonstrate that consumption of dietary fiber and whole grain 
intake is inversely related to obesity [1], type two diabetes [2], cancer [3] and cardiovascular disease 
(CVD) [4]. 
The Food and Drug Administration (FDA) has approved two health claims for dietary fiber. The 
first claim states that, along with a decreased consumption of fats (<30% of calories), an increased 
consumption  of  dietary  fiber  from  fruits,  vegetables  and  whole  grains  may  reduce  some  types  of 
cancer [5].  ―Increased  consumption‖  is  defined  as  six  or  more  one  ounce  equivalents,  with  three 
ounces derived from whole grains. A one ounce equivalent would be consistent with one slice of 
bread, ½ cup oatmeal or rice, or five to seven crackers.  
Recent  studies  support  this  inverse  relationship  between  dietary  fiber  and  the  development  of 
several types of cancers including colorectal, small intestine, oral, larynx and breast [3,6,7]. Although 
most studies agree with these findings, the mechanisms responsible are still unclear. Several modes of 
actions however have been proposed. First, dietary fiber (DF) resists digestion in the small intestine, 
thereby allowing it to enter the large intestine where it is fermented to produce short chain fatty acids, 
which have anti-carcinogenic properties [8]. Second, since DF increases fecal bulking and viscosity, 
there is less contact time between potential carcinogens and mucosal cells. Third, DF increases the 
binding between bile acids and carcinogens. Fourth, increased intake of dietary fiber yield increased 
levels of antioxidants. Fifth, DF may increase the amount of estrogen excreted in the feces due to an 
inhibition of estrogen absorption in the intestines [9].  
The  second  FDA  claim  supporting  health  benefits  of  DF  states  that  diets  low  in  saturated  fat 
(<10% of calories) and cholesterol and high in fruits, vegetables and whole grain, have a decreased 
risk of leading to coronary heart disease (CHD) [10]. For most, an increased consumption of dietary 
fiber is considered to be approximately 25 to 35 g/d, of which 6 g are soluble fiber.  
Obviously, many studies support the inverse relationship of dietary fiber and the risk for CHD. 
However, more recent studies found interesting data illustrating that for every 10 g of additional fiber 
added to a diet the mortality risk of CHD decreased by 17–35% [11,4]. Risk factors for CHD include 
hypercholesterolemia, hypertension, obesity and type two diabetes. It is speculated that the control and 
treatment of these risk factors underlie the mechanisms behind DF and CHD prevention. First, soluble 
fibers have been shown to increase the rate of bile excretion therefore reducing serum total and LDL 
cholesterol [12]. Second, short chain fatty acid production, specifically propionate, has been shown to 
inhibit cholesterol synthesis [13]. Third, dietary fiber demonstrates the ability to regulate energy intake 
thus enhancing weight loss or maintenance of a healthier body weight. Fourth, either through glycemic 
control or reduced energy intake, dietary fiber has been shown to lower the risk for type two diabetes. 
Fifth, DF has been shown to decrease pro-inflammatory cytokines such as interleukin-18 which may 
have  an  effect  on  plaque  stability  [14].  Sixth,  increasing  DF  intake  has  been  show  to  decrease 
circulating levels of C-Reactive protein (CRP), a marker of inflammation and a predictor for CHD [15]. Nutrients 2010, 2  
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Although only two claims have been adopted and supported by the FDA, multiple other ―potential 
claims‖ have been researched and well documented. Those conditions of particular importance, due to 
their  increasing  prevalence  among  the  general  population,  include  obesity  and  type  two 
diabetes [16,17]. The digestive physiology of dietary fiber has significant implications in the risk for, 
and treatment of, these metabolic disorders. Dietary fibers have been shown to result in decreased 
blood glucose excursions and attenuated insulin responses. This may be due to either a delayed [18] or 
decreased [1] intestinal absorption. Therefore, the purpose of the paper is to review current research 
regarding dietary fiber and whole grains in relation to these proposed claims. Focus will be placed on 
nutrient absorption, postprandial glycemia, insulin sensitivity, caloric density and satiety. Furthermore, 
select constituents of DF will be discussed in detail to better define their role in metabolic health.  
2. Defining Dietary Fiber 
In  the  simplest  form,  carbohydrates  can  be  separated  into  two  basic  groups  based  upon  their 
digestibility  in  the  GI  tract.  The  first  group  (i.e.,  starch,  simple  sugars,  and  fructans)  is  easily 
hydrolyzed  by  enzymatic  reactions  and  absorbed  in  the  small  intestine.  These  compounds  can  be 
referred  to  as  non-structural  carbohydrates,  non-fibrous  polysaccharides  (NFC)  or  simple 
carbohydrates. The second group (i.e., cellulose, hemicellulose, lignin, pectin and beta-glucans) are 
resistant  to digestion in  the small  intestine and  require bacterial fermentation located in the large 
intestine. These compounds can be referred to as complex carbohydrates, non-starch polysaccharide 
(NSP)  or  structural  carbohydrates  and  are  reflective  in  Neutral  Detergent  Fiber  (NDF)  and  Acid 
Detergent  Fiber  (ADF) analysis. NDF consists  of cellulose,  hemicelluloses and lignin  while ADF 
consists  of  cellulose  and  lignin.  However,  NDF  and  ADF  analysis  are  used  primarily  for  animal 
nutrition and the analysis of roughages.  
Although, NDF and ADF are typically not used in human nutrition, the separation of structural 
(NSP)  and  non-structural  carbohydrates  provide  the  basis  for  beginning  to  define  and  understand 
dietary fiber. This task has been a divergent process and has depended on both nutrition and analytical 
concepts. The most common and accepted definition is based on nutritional physiology. However, 
chemists and regulatory boards have leaned toward analytical procedures to factually define dietary 
fiber.  The  physiological  definition  is  easier  for  the  general  public  to  understand  and  adopt  for 
practical use.  
2.1. American Association of Cereal Chemists  
A recent description, as suggested by the American Association of Cereal Chemists [19], terms 
dietary fiber as carbohydrate polymers with more than a three degree polymerization which are neither 
digested nor absorbed in the small intestine. The greater than three degree polymer rule was designed 
to exclude mono and disaccharides. The known constituents of dietary fiber are listed in Table 1.  
This  definition  describes  in  more  detail  the  components  of  dietary  fiber  as  well  as  its  genetic 
makeup. Furthermore, the changes set forth in its description require few changes for its analytical 
evaluation [20]. 
   Nutrients 2010, 2  
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2.2. World Health Organization and Food and Agriculture Organization 
The World Health Organization (WHO) and Food and Agriculture Organization (FAO) agree with 
the American Association of Cereal Chemists (AACC) definition but with a slight variation. They state 
that dietary fiber is a polysaccharide with ten or more monomeric units which is not hydrolyzed by 
endogenous hormones in the small intestine [21]. 
Table 1. Components of dietary fiber according to the American Association of Cereal 
Chemists [22]. 
Non Starch Polysaccharides and Oligosaccharides   
  Cellulose         
  Hemicellulose       
  Arabinoxylans       
  Arabinogalactans       
  Polyfructoses       
  Inulin         
  Oligofructans       
  Galacto-oligosaccharides     
  Gums         
  Mucilages         
  Pectins         
Analagous carbohydrates       
  Indigestible dextrins       
  Resistant maltodextrins     
  Resistant potato dextrins     
  Synthesized carbohydrates compounds   
  Polydextrose       
  Methyl cellulose       
  Hydroxypropylmethyl cellulose     
  Resistant starches       
Lignin substances associated with the NSP and lignin complex 
  Waxes         
  Phytate         
  Cutin         
  Saponins         
  Suberin         
  Tannin         
2.3. Soluble versus Insoluble 
NSP can be further subdivided into the two general groups of soluble and insoluble. This grouping 
is based on chemical, physical, and functional properties [23]. Soluble fiber dissolves in water forming 
viscous  gels.  They  bypass  the  digestion  of  the  small  intestine  and  are  easily  fermented  by  the 
microflora  of  the  large  intestine.  They  consist  of  pectins,  gums,  inulin-type  fructans  and  some 
hemicelluloses. In the human GI tract, insoluble fibers are not water soluble. They do not form gels 
due to their water insolubility and fermentation is severally limited. Some examples of insoluble fiber Nutrients 2010, 2  
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are of lignin, cellulose and some hemicelluloses. Most fiber containing foods include approximately 
one-third soluble and two-third insoluble fiber [24]. 
3. Proposed Health Benefits of Dietary Fiber 
Dietary fiber and whole grains are an abundant source of nutrients including vitamins, minerals, and 
a slowly digestible energy. In addition, they contain phytochemicals such as phenolics, carotenoids, 
lignans, beta-glucan and inulin. These chemicals, secreted by plants, are not currently classified as 
essential  nutrients  but  may  be  important  factors  in  human  health  [25].  The  synergistic  effect  of 
phytochemicals, increased nutrient content and digestive properties, are believed to be the mechanism 
behind dietary fibers beneficial effects on the treatment and prevention of obesity and diabetes [1,26], 
reduced  CVD  [27]  and  decreased  incidence  of  certain  types  of  cancer  [28,29].  In  the  following 
subsections,  potential  health  benefits  of  dietary  fiber  will  be  reviewed  along  with  their  possible 
mechanisms and modes of actions. 
3.1. Obesity  
Approximately 66% of U.S. adults are overweight or obese [16] resulting in an increased risk of 
health  problems  including,  but  not  limited  to,  diabetes,  CVD,  and  certain  types  of  cancer  [30]. 
Although there are multiple factors that could contribute to obesity, the primary cause is due to an 
increase in the energy absorption:energy expenditure ratio. Therefore, limiting energy absorption is 
critical when treating obesity. Scientists have taken this a step further and studied the effect of other 
dietary aspects that may serve in weight regulation, including dietary fiber. Increasing dietary fiber 
consumption may decrease energy absorption by way of diluting a diet’s energy availability while 
maintaining other important nutrients.  
Substantial research has been conducted to evaluate the effect of dietary fiber and body weight, 
most  all  of  which  show  an  inverse  relationship  between  dietary  fiber  intake  and  change  in  body 
weight. Tucker and Thomas [1] supported this statement in a study consisting of 252 middle aged 
women. They observed that over a 20 month period participants lost an average of 4.4 lbs due to an 8 g 
increase in dietary fiber per 1000 kcal. This weight loss was primarily due to decreased body fat. It 
should be recognized that the correlation between dietary fiber and weight change was independent of 
many other potential factors including age, baseline fiber and fat intakes, activity level, and baseline 
energy intake.  
Koh-Banerjee  et  al.  [31]  concur  with  the  above  findings  and  also  suggest  a  dose-response 
relationship. They reported that for every 40 g/d increase in whole grain intake, weight gain decreased 
by 1.1 lbs. Moreover, bran seemed to play an important role in the reduction of weight gain by 0.8 lbs 
per 20 g/d intake.  
Dietary fiber’s ability to decrease body weight or attenuate weight gain could be contributed to 
several  factors.  First,  soluble  fiber,  when  fermented  in the  large intestine,  produces  glucagon-like 
peptide (GLP-1) and peptide YY (PYY) [32]. These two gut hormones play a role inducing satiety. 
Second, dietary fiber may significantly decrease energy intake [1]. Women who consumed increased 
levels of fiber tended to also have a decreased consumption of dietary fat. Third, dietary fiber may 
decrease a diets metabolizable energy (ME), which is gross energy minus the energy lost in the feces, Nutrients 2010, 2  
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urine and combustible gases. Baer et al. [33] observed that an increased consumption of dietary fiber 
resulted in a decrease in the ME of the diet. This may be attributed to the fact that fat digestibility 
decreased  as  dietary  fiber  increased.  Also,  as  dietary  fiber  intake  increases,  the  intake  of  simple 
carbohydrates tends to decrease. Although, dietary fiber still contributes to the total caloric content of a 
diet, it is much more resistant to digestion by the small intestine and even somewhat resistant in the 
large intestine.  
It should also be noted that the inverse relationship between dietary fiber and ME was independent 
of dietary fat. Therefore, ME decreased as dietary fiber increased in both high and low fat diets. 
However, when dietary fiber was split into soluble and insoluble fiber, the results were much more 
inconclusive. Soluble fiber decreased ME when added to a low fat diet but increased ME when added 
to a high fat diet [33]. It is not really known how dietary fat changes the effects of soluble fiber. 
Isken et al. [34] showed supportive data in mice consuming a high fat diet. Mice showed an increased 
weight gain when soluble fiber was added to a high fat diet. There are several mechanisms that may 
explain how soluble fiber could increase ME or weight gain. First, bacterial populations in the large 
intestine increase due to an increase in soluble fiber consumption [35]. This could result in increased 
fermentation and utilization of short chain fatty acids thereby increasing energy absorption. Second, 
soluble fiber enlarges in the GI and forms a viscous material which delays intestinal transit time [36]. 
Subsequently, this increase time in the GI tract may allow for more complete digestion and absorption. 
Conversely, some believe this increase viscosity has an opposite effect and retards absorption [26]. 
More research is needed in this area. 
Insoluble fiber seems to have the opposite effect to that of soluble. When insoluble fiber intake was 
increased  in  mice  consuming  a  high  fat  diet,  body  weight  decreased  [34].  Research  in  sows 
demonstrated that insoluble fiber decreased energy digestibility while it increased with soluble fiber 
intake [37]. The mode of action behind these findings may be due to the fact that insoluble fiber causes 
an increased rate of passage through the GI tract [38]. This would be expected to result in diminished 
digestion and absorption of nutrients.  
According to the data presented above, both soluble and insoluble fiber may lead to weight loss. 
However, there seems to be a relationship between the type of diet (high or low fat) and the type of 
fiber consumed. Insoluble fiber may play a more important role for weight loss during consumption of 
a high fat diet. Since resistant starch is a constituent of dietary fiber and undergoes the same digestion 
as insoluble fiber, comparing resistant starch and insoluble fiber may give us a better understanding of 
how dietary fiber can be used to treat and prevent obesity. Adding resistant starch to a diet dilutes its 
ME, but not to the degree of insoluble fiber [39]. 
Numerous  studies  [31,40]  have  found  the  same  inverse  relationship  between  dietary  fiber  and 
weight gain. However, the data are more inconsistent when comparing soluble and insoluble. Thus, 
although increasing dietary fiber in general has a favorable effect on body weight, more research is 
warranted to determine the optimal dietary fibers for the purpose of weight management.  
3.2. Diabetes 
Type two diabetes has increased exponentially over the past several years. Since 1990, self reported 
diabetes increased 61% [17]. Although other risk factors such as obesity, lack of physical activity and Nutrients 2010, 2  
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smoking are precursors for the disease, dietary factors also seem to play a significant role. Type two 
diabetes  results  from  decreased  insulin  sensitivity  and  hyperglycemia.  For  that  reason,  a  primary 
dietary factor of particular concern is carbohydrate intake.  
Meyer et al. [41] observed that total carbohydrates had no effect on the risk of diabetes. However, 
the type of carbohydrate (non structural carbohydrates and dietary fiber) was significantly related. 
Therefore, it is important to understand a foods glycemic index or load. Glycemic index ranks total 
carbohydrate intake according to their immediate postprandial glucose response in comparison to a 
reference group such as glucose or white bread. Carbohydrates with a low glycemic index result in a 
smaller glucose/insulin response. Simple small chain carbohydrates would be considered to have a 
higher glycemic index since it produces higher blood glucose concentrations.  
While Hu et al. [42] found that excess body fat was the single most important determinant of type 
two diabetes, poor nutrition was also a large influential factor. Moreover, women consuming a poor 
diet significantly increased their risk of developing type two diabetes. Poor diet was classified as a diet 
high in saturated fat, low dietary fiber and high non structural carbohydrates. This diet would be 
consistent  with  a  high  glycemic  load  being  higher  in  easily  digestible  and  rapidly  absorbable 
carbohydrates.  In  a  supportive,  long  term  (eight  year)  study  of  over  90,000  female  nurses, 
Shuzle et al. [43] found a positive correlation between glycemic index and risk of type two diabetes. 
This  association was significant even  after adjusting for age, body  mass index (BMI) and family 
history. Several means have been proposed to understand the physiology behind the relationship of 
glycemic index and diabetes. First, carbohydrates with a higher glycemic index produce higher blood 
glucose levels. This chronic hyperglycemia is suggested to lead to the dysfunction of beta cells in the 
pancreas  thus  decreasing  insulin  release.  Second,  due  to  an  over  abundance  of  energy  (i.e.,  high 
glycemic load) tissues such as skeletal muscle, liver and adipose become resistant to insulin.  
Although a majority of studies show a positive correlation between high glycemic foods and type 
two diabetes, several studies disagree with these findings. Meyer et al. [41] found that glycemic index 
had  no  effect  on  the  prevalence  of  diabetes  in  older  aged  women.  However,  there  was  a  strong 
(P = 0.005) inverse relationship between dietary fiber intake and diabetes when adjusted for age and 
BMI. Women consuming an average of 26 g/d of dietary fiber had a 22% lower risk of developing 
diabetes when compared to women only consuming 13 g/d. Schulze et al. [43] agreed with these 
findings with men and women showing a decreased risk of diabetes (P < 0.001) with the consumption 
of an additional 12 g of dietary fiber per day. According to these findings, it may be more significant 
to focus on an increased consumption of dietary fiber to prevent diabetes than glycemic index/load.  
It is important to note that the inverse relationship between dietary fiber and diabetes observed by 
Meyer et al. [41] and Schulze et al. [43] was independent of age and body weight. Hu et al. [42] 
supported  these  findings  while  correcting  for  age,  fat  intake,  smoking,  alcohol,  family  history, 
exercise, and body weight. Therefore, it seems that dietary fiber is associated with type two diabetes, 
independent of other compounding factors. 
According to recent research, the soluble versus insoluble fraction of fiber may give some insight 
on the efficacy of dietary fiber on diabetes and its mechanisms. Early research regarding soluble fiber 
demonstrated delayed gastric emptying and decreased absorption of macronutrients, resulting in lower 
postprandial blood glucose and insulin levels [44]. This is most likely due to the viscosity of soluble 
fibers inside the GI tract. Interestingly, different types of soluble fiber had varying effects on viscosity Nutrients 2010, 2  
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and nutrient absorption. Guar had the highest viscosity as well as the greatest effect at decreasing 
postprandial blood glucose. Therefore, it would be assumed that an increased level of soluble fiber 
would  be  associated  with  a  decreased  risk  of  diabetes.  However,  several  recent  studies  have 
demonstrated  the  opposite  showing  no  correlation  between  soluble  fiber  and  a  reduced  risk  of 
diabetes [41,43,45]. 
Although some studies have been contradictory, showing no differentiation between soluble and 
insoluble fiber on diabetes [43], a majority of the research demonstrates a strong inverse relationship 
between insoluble fiber and the risk of type two diabetes. Meyer et al. [41] using healthy middle aged 
women, observed a strong (P = 0.0012) inverse relationship between insoluble fiber and the risk of 
type two diabetes while soluble fiber had no effect. Montonen et al. [45] also found the same results in 
healthy middle aged men and women consuming increased levels of whole rye bread. Interestingly, 
fiber from fruits and vegetables had no effect on the risk of developing type two diabetes. Earlier 
studies have agreed with these findings. A large epidemiological study of 42,000 men found that 
dietary fiber from fruits or vegetables had no effect on the risk of diabetes. However, dietary fiber 
from whole cereal grains showed a significant decrease in diabetes occurrence [46]. Daily intakes of 
fiber among all groups were similar.  
Insoluble fiber only has a small effect on macronutrient absorption [44]. Therefore, another mode of 
action must be present and several hypotheses should be discussed. Some suggest that insoluble fiber 
increases the passage rate of foodstuff through the GI tract thus resulting in a decreased absorption of 
nutrients, namely simple carbohydrates. However, Weicket et al. [26] found that an increased intake of 
cereal fiber significantly improved whole body glucose disposal resulting in an 8% improvement of 
insulin sensitivity. This suggests that the mechanisms behind insoluble fiber are more peripheral and 
not limited to nutrient absorption. First, an accelerated secretion of glucose-dependent insulintropic 
polypeptide  (GIP)  was  observed  directly  after  the  ingestion  of  an  insoluble  fiber  in  healthy 
women [47].  GIP  is  an  incretin  hormone  which  stimulates  postprandial  insulin  release.  Second, 
insoluble fiber can result in a reduced appetite and food intake [48]. This may lead to a decreased 
caloric intake and BMI as described in the obesity section of this review. Third, short chain fatty acids, 
via fermentation, have been shown to reduce postpandrial glucose response [49,50]. Early research 
demonstrated that lipid infusions impaired glucose utilization [51] and oral acetate could decrease free 
fatty acids (FFA) in the blood [52]. According to Kelley and Mandarino [53], increases in FFA in the 
blood can inhibit glucose metabolism through the inhibition of GLUT 4 transporters. Therefore, short 
chain  fatty  acids,  by  way  of  decreasing  serum  free  fatty  acids,  may  reduce  blood  glucose  levels 
through competition in insulin-sensitive tissues.  
The inverse relationship between cereal grains and diabetes may also be attributed to an increased 
consumption of magnesium. Increased intake of magnesium has been shown to decrease the incidence 
of type two diabetes [41,54]. Hypomagnesemia is common among diabetics and has been associated 
with a reduction of tyrosine kinase at the insulin receptor [55]. This may impair the action of insulin 
thus leading to insulin resistance.  
According to recent research, increasing levels of dietary fiber may contribute a non-pharmacological 
way  to  improve  carbohydrate  metabolism.  However,  some  inconsistency  does  exist  and  may  be 
contributed to the classification of dietary fiber and whole grains. Subjects with diagnosed type two 
diabetes  may  also  add  to  the  irregularity  among  the  data.  In  a  study  of  men  and  women  with Nutrients 2010, 2  
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established diabetes, Jenkins et al. [56] observed that wheat bran had no effect on glycemic control in 
subjects with type two diabetes. Much of the research showing improved glycemia with dietary fiber 
examined healthy subjects, rather than subjects with diagnosed type two diabetes. Further research is 
needed to determine whether dietary fiber may be able to aid in the control of normal blood glucose 
levels in subjects with established type two diabetes.  
4. Fiber Components of Interest 
Dietary fiber can be separated into many different factions (Table 1). Recent research has begun to 
isolate these components and determine if increasing their levels in a diet is beneficial to human 
health. The separation of these fractions may give us a better understanding of how and why dietary 
fiber may decrease the risk for certain diseases. 
4.1. Arabinoxylan 
Arabinoxylan  (AX),  a  constituent  of  hemicelluloses,  is  comprised  of  a  xylose  backbone  with 
arabinose side chains. AX is a major component of dietary fiber in whole grains having considerable 
inclusions in both the endosperm and bran. In wheat, AX account for around 64–69% of the NSP in 
the bran and around 88% in the endosperm [57]. During normal wheat flour processing, a majority of 
the AX is removed as a by-product. In the GI tract, AX acts much like a soluble fiber being rapidly 
fermented by the microflora of the colon.  
Lu et al. [58], observed an inverse relationship between the intake level of an AX rich bread and 
postprandial glucose response in healthy adult subjects. When compared to the control, postprandial 
glucose levels were significantly lower with only 6 g of AX rich fiber supplementation while 12 g 
produced the greatest benefit. Breads high in AX also appear to control blood glucose and insulin in 
adults with an already impaired glucose tolerance [59]. Fasting blood glucose, postprandial blood 
glucose and insulin were all significantly lower when adults with type two diabetes were supplemented 
with 15 g/d of an AX rich fiber. The mode of action behind AX on improving glucose tolerance is 
unknown. However, it is thought to be due to the high viscosity of the fiber inside the lumen of the GI 
tract, thereby slowing the rate of glucose absorption. 
The lower glycemic index of AX may also play a role. Breads made with a flour rich in AX have a 
relatively low glycemic index of around 59. Whole wheat flour, although high in fiber, has a glycemic 
index of around 99 [58]. Arabinoxylan rich bread has a similar glycemic index to that of whole grain 
bread but offers some distinct advantages such as improved mouth feel and tenderness. There was no 
significant difference in the sensory analysis between the control and a bread containing 14% AX rich 
fiber [58].  
4.2. Inulin 
Inulin is a polymer of fructose monomers and is present in such foods as onions, garlic, wheat, 
artichokes and bananas and is used to improve taste and mouthfeel in certain applications. It is also 
used as a functional food ingredient due to its nutritional properties. Because of this, inulin products Nutrients 2010, 2  
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can be used as a replacement for fat or soluble carbohydrates without affecting the taste and texture 
and still contribute to a foods nutritional value.  
Enzymatic hydrolyses in the small intestine is minimal (<10%) since inulin consists of beta bonds. 
Therefore, it enters the large intestine and is almost completely metabolized by the microflora. When 
fermented, they tend to favor propionate production which, in turn, decreases the acetate to propionate 
ratio leading to decreased total serum cholesterol and LDL [13], which are important risk factors 
for CHD.  
Inulin has also demonstrated the ability to contribute to the health of the human large intestine as a 
prebiotic [60]. They demonstrated that inulin stimulated the growth of bifidobacteria while restricting 
the growth of potential pathogenic bacteria such as E. coli, Salmonella, and Listeria. This could prove 
to be beneficial in such disorders as ulcerative colitis and C. difficile infections. Rafter et al. [61] 
agreed with these findings and suggested they were the underlying mechanisms behind the observation 
that  inulin  decreased  biological  compounds  associated  with  colonic  cancer,  including  reduced 
colorectal  cell  proliferation  and  water  induced  necrosis,  decreased  exposure  to  genotoxins,  and 
decreased interleukin-2 release.  
Increased mineral absorption may also contribute to the functionality of inulin. Increased calcium 
absorption, by approximately 20%, was reported in adolescent girls supplemented with inulin [62]. 
Results from Abrams et al. [63], support these findings in a longer (one year) study of pubertal boys 
and girls consuming an inulin supplement. Subjects in the treatment group also experienced increased 
bone mineral density when compared to the control. The mechanisms behind these findings are still 
unclear  but  may  be  due  to  increased  calcium  absorption  from  the  colon  or  possibly  an  increased 
solubility in the lumen of the GI tract due to short chain fatty acids. Finally, it may increase absorption 
through an enhancement of vitamin D.  
Inulin may also provide a way to prevent and treat obesity. Cani et al. [64] demonstrated that 
oligofructose, a subgroup of inulin, increased satiety in adults which led to a decrease in total energy 
intake.  This  is  thought  to  be  due  to  short  chain  fatty  acids  and  their  ability  to  increase  appetite 
suppressing hormones such as glucagon-like peptide 1 (GLP-1).  
4.3. β-glucan 
β-glucan is a linear polysaccharide of glucose monomers with β(1→4) and β(1→3) linkages and 
found in the endosperm of cereal grains, primarily barley and oats. β-glucan concentrations in North 
American oat cultivars range from 3.9% to 6.8% [65]. β-glucan is water soluble and highly viscous at 
low concentrations [66]. 
The physiological benefits due to β-glucan seem to stem from their effect on lipid metabolism and 
postprandial  glucose  metabolism.  Many  studies  agree  an  inverse  relationship  exists  between 
consumption  levels  of  β-glucan  and  cholesterol  levels.  Several  recent  studies,  in  both 
hypercholesterolemic  [67]  and  healthy  [68]  subjects,  found  that  the  daily  consumption  of  5  g  of 
β-glucan significantly decreased serum total and LDL cholesterol. Davidson et al. [35] found that only 
a daily consumption of 3.6 g β-glucan was needed to produce the same significant effects. The same 
relationship also has been reported to occur between β-glucan and postprandial glucose and insulin 
responses in both diabetic and healthy subjects. Biorklund et al. [69] found that 5 g of β-glucan from Nutrients 2010, 2  
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oats significantly decreased postprandial glucose and insulin levels in healthy adults. Tappy et al. [70] 
reported the same results in adult subjects diagnosed with type two diabetes who consumed 4.0, 6.0 or 
8.4 g of β-glucan.  
Most authors agree that β-glucan’s viscosity in the GI tract is the most probable mechanism in 
which it decreases serum cholesterol levels as well as improves post prandial glucose metabolism. This 
gellation property may decrease bile acid absorption by increasing intestinal viscosity and increase bile 
acid excretion. This subsequently results in a higher hepatic cholesterol synthesis because of the higher 
need for bile acid synthesis [71]. The same viscosity may also delay glucose absorption into the blood 
thus lowering post prandial glucose and insulin levels. Nazare et al. [72] observed that 5 g of oat 
β-glucan  added  to  an  oat  concentrate  cereal  significantly  delayed,  but  did  not  reduce,  total 
glucose absorption.  
The production of short chain fatty acids from β-glucan may also be a probable mechanism behind 
its observed metabolic effects. Fermentation of oat β-glucan has been shown to yield larger amounts of 
propionate  [73,74].  Propionate  has  been  shown  to  significantly  inhibit  cholesterol  synthesis  in 
humans [13]  and  is  thought  to  be  due  to  the  inhibition  of  the  rate  limiting  enzyme  HMG  CoA 
reductase [75].  
Not all research however, agrees that β-glucan can affect lipid and glucose absorption/metabolism. 
Keogh et al. [76] observed that treatments of 8.1 to 11.9 g/d of barley β-glucan had no effect on total 
or LDL cholesterol in mildly hyperlipidemic adults. Cugent-Anceau et al. [77] not only observed that 
3.5 g of oat β-glucan added to soup did not alter serum lipid profiles, but also produced no change in 
postprandial glucose levels.  
The  inconsistency  between  studies  is  thought  to  be  due  to  the  molecular  weight  (MW)  and 
solubility of the β-glucan. The MW can be changed by several factors including food processing and 
the source of the β-glucan. Suortti et al. [78] states that heating, such as in extrusion and baking, 
decreases  the  molecular  weight  of  β-glucan  therefore  decreasing  its  viscosity  inside  the  GI  tract. 
Theuwissen and Meinsk [67] and Naumann et al. [68] both used a β-glucan obtained through a dry 
milling process in which it is not significantly degraded. Keogh et al. [78] however, obtained their 
β-glucan from a hot water extraction process which may have decreased MW and in turn intestinal 
viscosity. Kerckhoffs et al. [79] supports this theory as they observed that β-glucan, when added to 
bread or cookies, produced no change in the lipoprotein profile of mildly hypercholesterolemic adults. 
However, when the same β-glucan was added to orange juice, serum LDL decreased significantly. The 
bread baking process decreased the MW of the β-glucan. Unfortunately, this study failed to list the 
MW weight of the β-glucan in the orange juice.  
Different sources of β-glucan may also differ in their molecular weight and viscosity. Oats were the 
β-glucan  source  for  the  Theuwissen  and  Meinsk  [67]  and  Naumann  et  al.  [68]  studies  while 
Keogh et al. [76] utilized barley. Biorklund et al. [69] found similar results in that 5 g of β-glucan 
derived from oats significantly lowered serum cholesterol and postprandial glucose and insulin levels 
while the same level of β-glucan derived from barley produced no effects. Since the MW can vary 
among oat varieties [80] it may be safe to assume that the MW can also vary among cereal grain types.  
Oat and barley β-glucan also seem to differ in their solubility which would have a direct effect on 
intestinal viscosity. Gaidosova et al. [81] found that the solubility of barely β-glucan was significantly 
higher than that of oats.  Nutrients 2010, 2  
 
1277 
Oat and barley varieties may also play a role on the MW of β-glucan. Yao et al. [80] observed large 
differences in viscosity between β-glucan solutions from different oat varieties as a result of β-glucan’s 
wide range of molecular weights. Torronen et al. [82] using a lower MW (370,000 da) β-glucan found 
no  changes  in  serum  lipid  profiles  in  men  with  mild  to  moderate  hypercholesterolaemia  when 
compared to a control. Cugent-Anceau et al. [83], also using a low molecular weight (80,000 da) 
β-glucan, found similar negative results. However, when a high MW (1,200,000 da) β-glucan was 
used, it reduced serum cholesterol levels in the same class of subjects [84]. Kim et al. [73] disagreed 
with these findings when they reported that a lower molecular weight β-glucan bound significantly 
more bile acid in vitro. It should be noted however, that the β-glucan in this study was not in its natural 
form. Extracted β-glucan was treated with lichenase to yield the different molecular weights.  
4.4. Pectin 
Pectin is a linear polymer of galacturonic acid connected with α (1→4) bonds. Regions of this 
backbone are substituted with α (1→2) rhamnopyranose units from which side chains of neutral sugars 
such as galactose, mannose, glucose and xylose occur. Pectin is a water soluble polysaccharide that 
bypasses enzymatic digestion of the small intestine but is easily degraded by the microflora of the 
colon. Citrus fruit contains anywhere from 0.5% to 3.5% pectin with a large concentration located in 
the peel. Commercially extracted pectins are also available and are typically used in food applications 
which require a gelling or a thickening agent.  
Inside the GI tract, pectin maintains this ability to form a gel or thicken a solution. This is thought 
to  be  the  likely  mechanism  behind  its  many  beneficial  effects  on  health  including  dumping 
syndrome [85],  improved  cholesterol  and  lipid  metabolism  [86],  and  diabetes  prevention  and 
control [87].  However,  pectin  also  contains  some  unique  abilities  that  may  treat  or  prevent  other 
diseases/disorders such as intestinal infections, atherosclerosis, cancer and obesity.  
Several recent clinical studies, Rabbani et al. [88] and Triplehorn and Millard [89], demonstrated 
that  oral  pectin  supplementation  to  children  and  infants  reduced  acute  intestinal  infections  and 
significantly slowed diarrhea. This is thought to be due to a reduction in pathogenic bacteria such as 
Shigella,  Salmonella,  Klebsiella,  Enterobacter,  Proteus  and  Citrobacter.  This  is  supported  by 
Olano-Martin  et  al.  [90]  who  observed  that  pectin  stimulated  the  growth  of  certain  strains  of 
Bifidobacteria and Lactobacillus in vitro. These bacteria are considered to be directly related to the 
health of the large intestine and their concentrations depict a healthy microflora population.  
The  quality  of  fibrin  is  thought  to  be  an  important  risk  factor  for  atherosclerosis,  stroke  and 
coronary  heart  disease. Pectin has been shown to increase fibrin permeability and decrease fibrin 
tensile strength in hyperlipidaemic men [91]. Although the mechanism behind this is unknown, it is 
thought to be due in part to acetate production. Pectin yields predominantly acetate in the colon which 
is thought to enter peripheral circulation and alter fibrin architecture.  
Pectin  may  also  have  a  potential  role  in  the  complicated  area  of  cancer  prevention. 
Nangia-Makker et al. [92]  found  that  pectin  was  able  to  bind  to  and  decrease  tumor  growth  and 
cancerous cell migration in rats fed modified citrus pectin. This is thought to be a result of pectin 
binding to galectin-3 and inhibiting some of its functions. 
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4.5. Bran  
Bran is the outer most layer of a cereal grain and consists of the nucellar epidermis, seed coat, 
pericarp and aleurone. The aleurone consists of heavy walled, cube shaped cells which are composed 
primarily of cellulose. It is low in starch and high in minerals, protein, and fat. However, due to its 
thick cellulosic walls, these nutrients are virtually unavailable for digestion in monogastric species. 
The AACC defines oat bran as ―the food which is produced by grinding clean oat groats or rolled oats 
and separating the resulting oat flour by sieving bolting, and/or other suitable means into fractions 
such that the oat bran fraction is not more than 50% of the original starting material and has a total 
betaglucan content of at least 5.5% (dry-weight basis) and a total dietary fiber content of at least 
16.0% (dry-weight basis), and such that at least one-third of the total dietary fiber is soluble fiber.‖ [19]. 
Bran from a wide array of cereal grains have been shown to have an effect on postprandial glucose 
levels, serum cholesterol, colon cancer, and body mass. Although the efficacy of bran may change due 
to its source, the purpose of this section will just evaluate bran’s general effect on the parameters 
listed above.  
In a recent study of healthy adults, 31 g of rye bran decreased peak postprandial glucose levels by 
35% when compared to the control [93]. This effect may be due to the high AX content in rye bran. 
Arabinoxylan, as discussed previously, may increase intestinal viscosity and slow nutrient absorption. 
In a more lengthy study, Qureshi et al. [94] found that subjects suffering type one and two diabetes 
decreased their fasting glucose levels due to the daily consumption of 10 g of stabilized rice bran over 
two months. The results may arise due to an increased intestinal viscosity, but is more likely a result of 
a decreased carbohydrate/caloric intake. Koh-Banerjee et al. [31], in a larger clinical study, supports 
this  theory  in  their  finding  that  for  every  20  g/d  increase  in  consumption  of  bran,  body  weight 
decreased by 0.80 lbs. It should be noted that this data remained significant even after adjustment for 
fat  and  protein  intake,  daily  activity,  caloric  intake  and  baseline  weight.  In  an  earlier  study, 
Zhang et al. [95] observed that adults with ileostomies, consuming bread rich in rye bran, significantly 
increased the ileal excretion of fat, nitrogen and energy. This study suggests bran did not delay nutrient 
absorption in the small intestine but hindered it. 
In addition to a possible effect on carbohydrate absorption and metabolism, bran also seems to have 
the same effect on lipids. In a long term clinical study, Jensen et al. [96] reported that an increased 
daily consumption of bran significantly decreased the risk of coronary heart disease in healthy adult 
men. This is most likely due to the data reported by Qureshi et al. [94] who found that 10 g of rice bran 
consumed  for  eight  weeks  was  able  to  decrease  serum  total  cholesterol,  LDL  cholesterol  and 
triglycerides. The mechanisms behind these effects may be two fold. The reduction in cholesterol 
levels is likely due to an increase in bile acid synthesis. Andersson et al. [97] found that oat bran 
doubled the serum concentration of 7α-hydroxy-4-cholesten-3-one (α-HC), which is a metabolite in 
the  synthesis  of  bile  acids  that  is  oxidized  from  7α-hydroxycholesterol.  The  reduction  in  serum 
triglyceride levels may be a result of a decreased absorption of fat from the small intestine [95]. 
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4.6. Cellulose 
Cellulose is a linear chain of β(1→4) linked glucose monomers and is the structural component of 
cell walls in green plants and vegetables. It is water insoluble and inert to digestive enzymes in the 
small intestine. However, it can go through microbial fermentation to a certain degree in the large 
intestine in turn producing SCFA.  
Natural  cellulose  can  be  divided  into  two  groups:  Crystalline  and  amorphous.  The  crystalline 
component,  which  is  made  up  of  intra  and  intermolecular  non  covalent  hydrogen  bonds,  make 
cellulose  insoluble  in  water.  However,  many  modified  celluloses  such  as  powdered  cellulose, 
microcrystalline cellulose and hydroxypropylmethyl cellulose have been developed and are used as 
food ingredients. The difference between natural and modified celluloses is the extent of crystallization 
and hydrogen bonding. When these hydrogen bonds are disrupted and the crystallinity is lost, the 
cellulose derivative becomes water soluble [98]. 
Little research has been conducted evaluating the effects of cellulose in humans. Therefore, studies 
in  other  models  such  as  the  rat  will  be  discussed.  The  translation  to  human  relevance  is  poorly 
understood and debatable. Cellulose pills have been made available for human consumption with the 
theory that cellulose may decrease a person’s caloric intake. Although no human studies could be 
found to support this, several animal studies using cats [99], dogs [100] and rats [101] have shown that 
increasing dietary cellulose can reduce daily energy intake. This is most likely a dilution factor since 
cellulose is virtually undigested in the small intestine and only 51% metabolized by the microflora of 
the colon.  
Many studies have evaluated the effect of cellulose on blood glucose and insulin levels in many 
different models. However, the data is extremely contradictory and may depend on the subject, type of 
cellulose and other unknown factors. Using the rat [102], dog [103] and cat [104], natural cellulose 
was shown to decrease postprandial glucose and insulin levels. However, similar studies in pigs [105] 
and humans [106] demonstrated that natural cellulose had no effect on these parameters. Studies using 
modified celluloses showed more consistent data. Microcrystalline cellulose has shown the ability to 
decrease blood glucose levels in the pig [107] and rat [108]. Complimenting this, methylcellulose had 
demonstrated the same effects in humans. Lightowler and Henry [109] found that adding only 1% high 
viscosity  hydroxypropylmethylcellulose  (HV-HPMC)  to  mashed  potatoes  decreased  postprandial 
glucose levels by 37% in healthy adults. Also, Maki et al. [110] reported an acute 35% reduction in 
postprandial blood glucose due to 4 g of HV-HPMC in overweight subjects.  
Modified cellulose has also been reported to effect lipid metabolism. Maki et al. [111,112] both 
observed  a  significant  reduction  in  total  and  LDL  cholesterol  in  hypercholesterolemic  adults 
consuming 5 g/d of HV-HPMC for four weeks. Interestingly, in subjects already receiving statin drugs, 
HV-HPMC was able to further reduce total and LDL cholesterol.  
According  to  this,  modified  celluloses  may  be  more  beneficial  than  natural  cellulose.  These 
modified celluloses, as described above, act like soluble fiber thus adding to the viscosity of the GI 
tract.  Therefore,  it  is  assumed  that  increased  intestinal  viscosity  delays  nutrient  absorption  and 
increases bile acid excretion.  
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4.7. Resistant Starch 
Resistant starches (RS) are defined as any starch not digested in the small intestine [113]. RS 
behaves like soluble fiber without sacrificing palatability and mouth feel. Thus, resistant starch tries 
combining the health benefits of dietary fiber/whole grain with the sensory feel of refined carbohydrates.  
RS  has  been  classified  into  four  basic  ―types‖.  Type  1  (RS1)  is  made  up  of  starch  granules 
surrounded by an indigestible plant matrix. Type 2 (RS2) occurs in its natural form such as in an 
uncooked potato and high amylose maize. Type 3 (RS3) are crystallized starches made by unique 
cooking  and  cooling  processes.  Type  4  (RS4)  is  a  starch  chemically  modified  by  esterification, 
crosslinking, or transglycosylation and is not found in nature. Few studies have compared types, but 
one  recent  study  by  Haub  et  al.  [114]  reported  that  cross-linked  RS4  elicited  a  greater  glucose 
lowering effect than the more commonly tested RS2.  
A majority of human studies involving RS have shown a decrease in postprandial blood glucose and 
insulin levels. However, it is difficult to completely understand these effects due to differences in 
study design and the type of RS used. Behall et al. [115] found that women consuming 0.71 g, 2.57 g 
or 5.06 g of RS had significantly lower postprandial glucose and insulin levels when compared to the 
control. However, this study failed to maintain an equal amount of available carbohydrate between the 
treatments and control. Therefore, it is difficult to determine whether the attenuation of glucose and 
insulin was due to the RS or the fact that there was less available carbohydrate in the meal. Similarly, 
Reader et al. [116] reported that 7.25 g of RS added to an energy bar decreased blood glucose and 
insulin  levels  in  healthy  adults.  But,  ingredients,  amount  of  ingredients  and  nutrient  levels  were 
different  for  each  treatment.  A  recent  study  by  Al-Tamimi  et  al.  [117],  however  removed  these 
variables by controlling for non starch ingredients and available carbohydrates. It was reported that 
postprandial blood glucose and insulin levels were significantly reduced with the supplementation of 
30 g of RS4. 
Several studies report that longer term consumption of a RS may decrease fasting cholesterol and 
triglyceride levels. In a five week study, Behall et al. [118] found that men consuming 34% of their 
energy  from  high  amylose  maize,  when  compared  to  a  high  amylopectin  carbohydrate,  had 
significantly reduced fasting cholesterol and triglyceride levels. Resier et al. [119] reported similar 
results in an isocaloric and isonutrient diet with either high amylose maize or fructose. Porikos and 
Van Itallie [120] suggest that an interaction exists between sucrose, and therefore most likely fructose, 
and saturated fatty acids in turn promoting serum triglyceride levels. Interestingly, the relationship 
does not seem to exist for polyunsaturated fatty acids. The likely mechanism behind the ability of RS 
to  decrease cholesterol  levels  is an increased intestinal viscosity. However, some studies,  such  as 
Jenkins et al. [121], report conflicting data as RS2 and RS3 had no effect on serum lipid profiles. 
While using the same type of RS, subjects were only tested for two weeks. It may be that the RS 
requires a longer period of time to promote an effect.  
Research has also been conducted which evaluates the effect of RS on fat oxidation and storage. 
However, data between studies are contradictory with no clear conclusions. Tagliabue et al. [122] 
reported that RS2, obtained from raw potatoes, was able to increase fat oxidation 5 h postprandial. 
However, the test diet, consisting of the RS2, had significantly less gross and metabolizable energy. 
Therefore, it is difficult to determine if the increased fat oxidation was due to the RS2 or a decreased Nutrients 2010, 2  
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caloric intake. A 10 week study by Howe et al. [123] may suggest the latter. High amylose starch, 
compared to a high amylopectin, produced no change on fat oxidation when an isocaloric diet was 
consumed. Conversely, Robertson et al. [124] reported that 30 g of RS2 added to healthy subjects 
habitual diet resulted in a significant decrease in subcutaneous abdominal adipose tissue non-esterfied 
fatty acid (NEFA) and glycerol release. This may be a result of increased peripheral SCFA metabolism 
or ghrelin secretions.  
5. Conclusions 
In a simplified definition, dietary fiber is a carbohydrate that resists digestion and absorption and 
may or may not undergo microbial fermentation in the large intestine. This definition is essentially the 
basis to its correlation between consumption levels and possible health benefits. Dietary fiber consists 
of many different constituents, however; some are of particular interest and include arabinoxylan, 
inulin, β-glucan, pectin, bran and resistant starches. These individual components of dietary fiber have 
been shown to significantly play an important role in improving human health. Current research is 
paying particular attention to these elements; although further research is needed to better understand 
particular health claims and the mechanisms involved.  
A large amount of research has reported an inverse relationship between fiber consumption and the 
risk for coronary heart disease and several types of cancer. For that reason, the FDA has adopted and 
published the claim that increased consumption of dietary fiber can reduce the prevalence of coronary 
heart diseases and cancer. The mechanisms behind these findings are still unclear. However, it is 
thought to be attributed to several factors including increasing bile acid excretion, decreased caloric 
intake, increased short chain fatty acid production, carcinogen binding effects, increased antioxidants, 
and increased vitamins and minerals. 
Although not as yet adopted by the FDA, dietary fiber is suggested to play a role in other conditions 
such as obesity and diabetes. Although some data are contradictory, a majority of studies regarding 
dietary fiber report a decrease of these two conditions with increased consumption of fiber.  
The digestive and viscosity characteristics of dietary fiber are the likely modes of action which 
affect diabetes and obesity risk. These mechanisms appear to decrease nutrient absorption, therefore, 
decreasing metabolizable energy. Dietary fiber may also be able to decrease gross energy of a food due 
to its lower energy density.  
Further studies are needed in certain areas of dietary fiber research. Those of particular interest are 
in the components of fiber such as β-glucan, arabinoxylan, resistant starches, etc. These sub fractions 
may give a better understanding of the health benefits of dietary fiber as well as the mechanisms 
behind them.  
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